Form 4: Toquet Gweltaz reports acquisition/exercise transactions in CEVA

Rhea-AI Filing Summary

Toquet Gweltaz reported acquisition or exercise transactions in a Form 4 filing for CEVA. The filing lists transactions totaling 4,585 shares. Following the reported transactions, holdings were 56,363 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Toquet Gweltaz

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,585	$0.00	--

Holdings After Transaction: Common Stock — 56,363 shares (Direct)

Footnotes (1)

1. Represents shares subject to restricted stock units (RSUs) with respect to which performance-based vesting conditions have been satisfied. The performance-based RSUs were issued under the 2011 Equity Incentive Plan and will vest 33.4% on February 15, 2026, 33.3% on February 15, 2027 and 33.3% on February 15, 2028. Represents 24,772 shares outstanding and 31,591 unvested RSU's.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Toquet Gweltaz

(Last) (First) (Middle)

CEVA, INC.

15245 SHADY GROVE ROAD, SUITE 400

(Street)

ROCKVILLE MD 20850

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CEVA INC [ CEVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/15/2026		A		4,585(1)	A	$0	56,363(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares subject to restricted stock units (RSUs) with respect to which performance-based vesting conditions have been satisfied. The performance-based RSUs were issued under the 2011 Equity Incentive Plan and will vest 33.4% on February 15, 2026, 33.3% on February 15, 2027 and 33.3% on February 15, 2028.

2. Represents 24,772 shares outstanding and 31,591 unvested RSU's.

	/s/ Gweltaz Toquet	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CEVA (CEVA) report for Gweltaz Toquet?

CEVA reported that Chief Commercial Officer Gweltaz Toquet acquired 4,585 shares of common stock on February 15, 2026. The shares were received at a price of $0 per share as part of a grant or award, not through an open-market purchase.

What type of equity award did CEVA (CEVA) grant to its Chief Commercial Officer?

The award consists of performance-based restricted stock units (RSUs) granted under CEVA’s 2011 Equity Incentive Plan. Vesting occurs in three tranches, subject to satisfied performance conditions, rather than being immediately and fully transferable like standard purchased shares.

How will Gweltaz Toquet’s CEVA (CEVA) RSUs vest over time?

The performance-based RSUs vest in three installments: 33.4% on February 15, 2026, 33.3% on February 15, 2027, and 33.3% on February 15, 2028. This schedule spreads the equity compensation over three years, aligning with longer-term service and performance.

How many CEVA (CEVA) shares does Gweltaz Toquet own after the reported transaction?

After the transaction, Gweltaz Toquet beneficially owns 56,363 CEVA shares. This total includes 24,772 shares currently outstanding in his name and 31,591 unvested restricted stock units that will vest over the specified schedule if conditions are met.

Was the CEVA (CEVA) insider transaction an open-market stock purchase?

No. The filing identifies the transaction code as a grant, award, or other acquisition at $0 per share. This indicates the shares were received as equity compensation via restricted stock units rather than being purchased in the open market.

What role does Gweltaz Toquet hold at CEVA (CEVA) in this Form 4 filing?

Gweltaz Toquet is identified as CEVA’s Chief Commercial Officer. The Form 4 notes his status as an officer of the company and reports the equity award and his resulting beneficial ownership as part of his executive compensation.